Century Therapeutics, Inc. (IPSC) Total liabilities 2022–2025
Century Therapeutics, Inc. (IPSC) total liabilities at each fiscal year-end, per SEC filings.
$64.8MFY2025 · since FY2022: $183.8M → $64.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $64.8M | -66.2% |
| FY2024 | $191.9M | +9.0% |
| FY2023 | $175.9M | -4.3% |
| FY2022 | $183.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More IPSC financial trends
IPSC RevenueIPSC Net incomeIPSC Net marginIPSC Gross profitIPSC Gross marginIPSC Operating incomeIPSC Operating marginIPSC Operating cash flowIPSC Free cash flowIPSC Capital expendituresIPSC Return on equityIPSC Stock buybacksIPSC Dividends paidIPSC Total assetsIPSC Shareholders’ equityIPSC overview →